Loperamide hydrochloride and Simethicone
NDC 69452-210, loperamide hydrochloride and simethicone, tablet, from Bionpharma Inc..
- Product NDC
- 69452-210
- Status
- Listed
- Labeler
- Bionpharma Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213484
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LOPERAMIDE HYDROCHLORIDE2 mg/1
- DIMETHICONE125 mg/1
Pharmacologic classes
Opioid Agonist [EPC]; Opioid Agonists [MoA]; Skin Barrier Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-210-04 | 69452021004 | 1 BLISTER PACK in 1 CARTON (69452-210-04) / 6 TABLET in 1 BLISTER PACK |
| 69452-210-12 | 69452021012 | 4 BLISTER PACK in 1 CARTON (69452-210-12) / 6 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69452-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.